Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone
暂无分享,去创建一个
Jing Xie | Eva K Fenwick | Ryan E K Man | Ecosse L Lamoureux | T. Wong | C. Sabanayagam | E. Lamoureux | Tien Y Wong | G. Rees | L. Lim | Lyndell Lim | Gwyn Rees | Charumathi Sabanayagam | E. Fenwick | R. Man | Jing Xie | T. Wong | T. Wong | T. Wong
[1] T. Wong,et al. Rationale and Methodology for a Population-Based Study of Eye Diseases in Malay People: The Singapore Malay Eye Study (SiMES) , 2007, Ophthalmic epidemiology.
[2] T. Wong,et al. Glycemic and blood pressure control in an asian malay population with diabetes and diabetic retinopathy. , 2010, Archives of ophthalmology.
[3] R. Klein,et al. The Epidemiology of Eye Diseases in Diabetes , 2008 .
[4] C. Sabanayagam,et al. HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics , 2017, Journal of diabetes.
[5] B. Hoogwerf,et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. , 1996, Archives of ophthalmology.
[6] G. Dagenais,et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. , 2001, Archives of internal medicine.
[7] Malla Ok,et al. Vision 2020: the right to sight. , 2004, Kathmandu University medical journal.
[8] R. Raman,et al. Prevalence and Risk Factors of Diabetic Retinopathy in Subjects with Suboptimal Glycemic , Blood Pressure and Lipid Control , 2012 .
[9] T. Sano,et al. [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[10] Matthew D. Davis,et al. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.
[11] K. Pesudovs,et al. The impact of diabetic retinopathy: understanding the patient's perspective , 2010, British Journal of Ophthalmology.
[12] R. Raman,et al. Prevalence and Risk Factors of Diabetic Retinopathy in Subjects with Suboptimal Glycemic, Blood Pressure and Lipid Control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33) , 2012, Current eye research.
[13] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[14] S. Arcona,et al. Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease , 2015, ClinicoEconomics and outcomes research : CEOR.
[15] R. Bullock,et al. Validation of a 6 item cognitive impairment test with a view to primary care usage , 1999, International journal of geriatric psychiatry.
[16] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[17] T. Wong,et al. Management of diabetic retinopathy: a systematic review. , 2007, JAMA.
[18] Rury R Holman,et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. , 2008, The New England journal of medicine.
[19] J. Shaw,et al. Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab. , 2005, Diabetes care.
[20] Vishali Gupta,et al. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. , 2004, American journal of ophthalmology.
[21] M. Woodward,et al. Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes , 2009, Diabetes Care.
[22] R. Raman,et al. Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13. , 2010, Ophthalmology.
[23] R. Hogg,et al. Dyslipidemia and Diabetic Macular Edema: A Systematic Review and Meta-Analysis. , 2014, Ophthalmology.
[24] G. Chodick,et al. The association between glycemic, lipids and blood pressure control among Israeli diabetic patients. , 2007, QJM : monthly journal of the Association of Physicians.
[25] S. Hori. Guidelines for the Management of Diabetic Retinopathy for the Internist , 2002 .
[26] W. Howard. Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study , 2008 .
[27] S. Grundy,et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus , 2006, Diabetes Care.
[28] D. Budescu. Dominance analysis: A new approach to the problem of relative importance of predictors in multiple regression. , 1993 .
[29] S. Saydah,et al. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.
[30] T. Wong,et al. Methodology and early findings of the Diabetes Management Project: a cohort study investigating the barriers to optimal diabetes care in diabetic patients with and without diabetic retinopathy , 2012, Clinical & experimental ophthalmology.
[31] Walter T Ambrosius,et al. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. , 2014, Ophthalmology.
[32] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[33] Sarah J. Beaton,et al. Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. , 2004, Diabetes care.
[34] Stephen J. Aldington,et al. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.